Clinical Trial Update: Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE) [Phase 1, Phase 2]

View source ↗

Summary

A long-term safety update from a Phase 1/2 trial evaluating Alpha1-Proteinase Inhibitor (Human) in Japanese subjects with Alpha1 Antitrypsin Deficiency (GTI1401…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha1-antitrypsin Deficiency

Drugs mentioned

• Alpha1-Proteinase Inhibitor (Human) (alpha1-proteinase inhibitor (human))

Snippet

Sponsor: Grifols Therapeutics LLC | Conditions: Alpha1-Antitrypsin Deficiency | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-03-21